Vectura has built its portfolio based on the Company's expertise in product development, formulation, and drug delivery. It currently focuses on the development of inhaled products to meet the unaddressed requirements in airways diseases. The company is committed to addressing the needs of all stakeholders, including patients, physicians, and payors, while also prioritizing commercial appeal and leveraging valuable opportunities in the therapeutic field.